Janssen nabs new prostate patient group
Janssen received a double win in prostate cancer this week after bagging US
approval to extend Zytiga and market new drug Erleada, with the latter filed only four months ago.
Too early to think election? Think again
If you're not thinking about the PBS in an election context, then think again. With a federal election looming, the government is already viewing spending through its pre-election lens.